Actively Recruiting

Phase Not Applicable
Age: 6Years - 9Years
All Genders
NCT06730360

Clinical and Radiographic Assessment of Photobiomodulated MTA Pulpotomy in Immature First Permanent Molars with Irreversible Pulpitis

Led by Mansoura University · Updated on 2024-12-17

72

Participants Needed

1

Research Sites

77 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study evaluates the effectiveness of photobiomodulation (PBM) in conjunction with mineral trioxide aggregate (MTA) pulpotomy for treating irreversible pulpitis in immature first permanent molars. PBM, also known as low-level laser therapy (LLLT), is used to enhance healing, reduce inflammation, and manage pain in young teeth. The randomized clinical trial involves 72 children aged 6-9 years, divided into two groups: one receiving MTA pulpotomy alone and the other receiving MTA pulpotomy with PBM. Clinical and radiographic outcomes will be assessed at intervals over 15 months. This research aims to determine the combined therapy's efficacy in improving pulp healing and reducing post-operative discomfort compared to MTA alone.

CONDITIONS

Official Title

Clinical and Radiographic Assessment of Photobiomodulated MTA Pulpotomy in Immature First Permanent Molars with Irreversible Pulpitis

Who Can Participate

Age: 6Years - 9Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged 6 to 9 years
  • Healthy children with no significant medical history
  • Presence of carious first permanent molars with deep decay extending to at least two-thirds of the dentin
  • Positive response to cold testing
  • Clinical diagnosis of moderate or severe irreversible pulpitis, with or without periapical periodontitis
  • Restorable tooth
  • Normal probing pocket depth and tooth mobility
  • No signs of pulpal necrosis, including absence of sinus tract or swelling
Not Eligible

You will not qualify if you...

  • Insufficient bleeding after pulp exposure indicating necrotic or partially necrotic pulp
  • Presence of systemic or medical conditions contraindicating participation
  • Teeth with unrestorable structure
  • Teeth showing signs of pulpal necrosis such as sinus tract or swelling

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Faculty of Dentistry

Al Mansurah, Dakahlia Governorate, Egypt, 35516

Actively Recruiting

Loading map...

Research Team

P

peter samir abdelshahed, assistant lecture

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here